Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-omics Study and Drug Intervention Study of Spondyloarthritis

NCT05494203 is registered in ClinicalTrials.gov with First Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT05494203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05494203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-omics Study and Drug Intervention Study of Spondyloarthritis
Lead sponsor
First Affiliated Hospital of Wenzhou Medical University
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2022
Completion date
July 31, 2023
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spondylarthritis